Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 20:51:47 - browse：138

Courtesy Guardant Health

An independent panel of advisers to the Food and Drug Administration recommended the agency approve Guardant Health’s blood-based colon cancer detection test. If the agency follows the recommendation, it will clear an early hurdle for the test’s broader adoption.

The expert panel spent hours listening to presentations from Guardant, the FDA, and members of the public before voting on the screening test, called Shield. The panel’s nine voting members then voted on whether the test was safe, effective, and whether its benefits outweigh its risks, with eight, six, and seven panelists endorsing those views, respectively.

FDA approval is a requirement for winning coverage from the Centers for Medicare and Medicaid Services, which could be the difference between Guardant’s test becoming widespread — or irrelevant. In 2021, CMS denied coverage for Epi proColon, a different blood-based colon cancer test approved by the FDA. Soon after, the test’s maker, Epigenomics, announced that it would stop actively marketing the test, and last year the company announced a restructuring that included layoffs.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Why do women spend more than men on medical expenses?

WSS

FDA advisers vote against ALS treatment from BrainStorm

4th of July breaks record for highest global temperature ever measured

FDA advisers vote against ALS treatment from BrainStorm

Can food be medicine? And other questions about a new push

Listen: Biogen's messy board & Laronde's data problem

STAT Virtual Event: How to Increase Diversity in Clinical Trials

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Jerome Adams on the need for new antivirals for Covid

Biogen shutters digital health group, ends Apple study, in cost cutting move

Cancer drug shortages should be causing more outrage

Doctor appointment wait times are getting worse

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Brain 'hot spot' may explain why African Americans feel greater pain

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pfizer's Covid pill remains 89% effective in final analysis, company says

Novavax promises a turnaround & Lilly roils the obesity market

Mindstrong's demise and the future of mental health care

focus

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Data show record exodus of life scientists from academia

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Biogen shutters digital health group, ends Apple study, in cost cutting move

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

How one patient went off dialysis — and others can too

knowledge

focus

hotspot

Wikipedia